# Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama

> **NCT00653198** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 885 (actual)

## Conditions studied

- Infections, Rotavirus

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT00653198
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03-19
- **Primary completion:** 2011-03-18
- **Final completion:** 2011-03-18
- **Target enrollment:** 885 (ACTUAL)
- **Last updated:** 2017-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00653198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00653198, "Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00653198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*